Pieter M. ter Wee - Concepedia

Author

Pieter M. ter Wee

Amsterdam UMC Location Vrije Universiteit Amsterdam

Also Known As

Nynke Posthuma, P M Ter Wee, P M ter Wee, P. M. Ter Wee, P. M. Wee, P. M. ter Wee, P.M. Ter Wee, P.M. ter Wee, PM ter Wee, Pieter M ter Wee

117

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam University of Amsterdam Vrije Universiteit Amsterdam University of Groningen Erasmus MC

About

Pieter M. ter Wee is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in nephrology, medicine, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	942
2	Health Sciences	3	3	79
3	Biomedical Engineering	2	2	56
4	Engineering	1	1	12
5	Biochemistry	1	1	39

Pieter M. ter Wee

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Randomized, Clinical Trial Comparison of Trisodium Citrate 30% and Heparin as Catheter-Locking Solution in Hemodialysis Patients Marcel C. Weijmer, Marinus A. van den Dorpel, Peter J.G. van de Ven, Journal of the American Society of Nephrology DialysisDialysis TherapyCatheter CharacteristicsCatheter Flow ProblemsHemodialysis Patients	2005	300
Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial Louise Schilder, Shaikh A. Nurmohamed, Frank H. Bosch, Critical Care	2014	180
Induction of 1,2-Dicarbonyl Compounds, Intermediates in the Formation of Advanced Glycation End-Products, during Heat-Sterilization of Glucose-Based Peritoneal Dialysis Fluids Casper G. Schalkwijk, N Posthuma, H.J. ten Brink, Peritoneal Dialysis International	1999	141
Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance N Posthuma, Pieter M. ter Wee, Henri A. Verbrugh, Nephrology Dialysis Transplantation	1997	137
A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: part 2: renal replacement therapy Achim Jörres, Stefan John, Andrew Lewington, Nephrology Dialysis Transplantation Kdigo GuidelineDialysis TherapyClinical Practice GuidelinesRenal FunctionSepsis	2013	80
Oral and salivary changes in patients with end stage renal disease (ESRD): a two year follow-up study C.P. Bots, H.S. Brand, J.H.G. Poorterman, BDJ HemodialysisSalivary ChangesRenal FunctionMedicineKidney Failure	2007	75
Section I. Measurement of renal function, when to refer and when to start dialysis M. Kessler, Bernard Canaud, Luciano A. Pedrini, Nephrology Dialysis Transplantation GlomerulonephritisHemodialysisUrologyRenal DiseaseRenal Function	2002	75
Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo Liesbeth H.P. Hekking, Angelique G.A. Welten, B. A. J. Driesprong, Nephrology Dialysis Transplantation	2003	68
Peritoneal Kinetics and Mesothelial Markers in CCPD Using Icodextrin for Daytime Dwell for Two Years N Posthuma, Henri A. Verbrugh, A. J. M. Donker, Peritoneal Dialysis International	2000	66
Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell. N Posthuma, Pieter M. ter Wee, A. J. M. Donker, PubMed	1998	60

Page 1